z-logo
open-access-imgOpen Access
Significance of iron reduction for the therapy of chronic hepatitis C
Author(s) -
Darko Nožić,
Bela Balint,
Nebojša Stanković,
J Dimitrijević,
Goraesković
Publication year - 2005
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0502161n
Subject(s) - medicine , phlebotomy , ribavirin , chronic hepatitis , pegylated interferon , hepatitis c , gastroenterology , hepatitis c virus , immunology , hepatitis , viral hepatitis , interferon , virus
It has been established that many patients with chronic hepatitis C have elevated serum iron, feritin levels and iron deposites in the liver. Therefore, the liver damage due to hepatitis C virus may be aggravated with iron overload. In many studies higher levels of iron in the blood and the liver were connected with the decreased response to interferon-alfa therapy for chronic viral hepatitis C. Recent introduction of pegylated interferons plus ribavirin has improved the therapeutic response, so it is now possible to cure more than 50% of the patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom